ABNB vs HCAT
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 18, 2026
ABNB
HCAT
Investment Advisor Scores
HCAT
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ABNB | HCAT | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 35.3357 | 7.764 | HCAT |
| PEG Ratio | 1.9742 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 16.5% | -12.7% | ABNB |
| Earnings Growth | 33.4% | 0.0% | ABNB |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 35.2/100 | 55.5/100 | HCAT |
| Profit Margin | 20.4% | -90.6% | ABNB |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ABNB
MarkupPrice above SMA50, rising 50-day trend (10.2% over 20 days), RSI 72
HCAT
NeutralMixed signals - no dominant trend phase, RSI 32
Fundamentals Snapshot
| Metric | ABNB | HCAT |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 30.3 | 38.4 |
| Trailing P/E | 42.5 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | -0.1% |
| Gross Margin | 0.8% | 0.5% |
| Operating Margin | 0.2% | -0.1% |
| EPS | 4.35 | -3.54 |
| Dividend Yield | — | — |